Abbott Laboratories (ABT) Hisse Fiyat
Abbott Laboratories Fiyat
Abbott Laboratories, son 19 yılda gelirini yıllık %3,6 artırarak 44,33 Md USD seviyesine taşıdı. Hisse başına kâr, son 19 yılda yıllık %6,6 büyüdü. Abbott Laboratories için net marj, %14,7 ile birkaç yıl önceki %16,4 seviyesine göre geriledi. Bugünkü fiyata göre temettü verimi kabaca %2,30 seviyesine denk geliyor. Temettü dağıtım oranı, kârın yaklaşık %63 düzeyindedir. Temettü, son 19 yılda yıllık %3,8 artış gösterdi. Abbott Laboratories için 12 aylık konsensüs fiyat hedefi 121,00 USD; bu, hissenin bugünkü fiyatının yaklaşık %17,9 üzerinde bir seviyeye denk geliyor. 32 analistten 26 tanesi hisse için alım öneriyor — genel konsensüs: Al.
Abbott Laboratories hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Abbott Laboratories iş modeli ve hisse analizi
Abbott Laboratories hakkında sık sorulan sorular
Abbott Laboratories is a renowned healthcare company with a strong business model focused on providing a diverse range of medical products, diagnostics, nutritional supplements, and pharmaceuticals. By combining technological advancements with innovative research, Abbott aims to enhance the quality of life for individuals worldwide. With a comprehensive portfolio spanning diverse healthcare sectors, including diagnostics, nutrition, diabetes care, medical devices, and branded generic pharmaceuticals, Abbott Laboratories strives to improve patient outcomes and deliver sustainable growth. Through its commitment to scientific excellence and dedication to meeting evolving healthcare needs, Abbott Laboratories has established itself as a trusted leader in the global healthcare industry.
Abbott Laboratories is primarily active in the healthcare industry.
The main competitors of Abbott Laboratories in the market are Johnson & Johnson, Pfizer, and Roche Holding AG.
Abbott Laboratories is a renowned American healthcare company, known for providing a diverse range of medical, pharmaceutical, and nutritional products. Founded in 1888 by Dr. Wallace C. Abbott, the company initially focused on producing pharmaceuticals, including the widely successful alkaloid-based pain reliever, Abbott's ABC Liniment. Over the years, Abbott Laboratories has expanded its portfolio, venturing into areas such as diagnostics, medical devices, and nutrition. The company's commitment to innovation is evident through breakthroughs like the development of the first HIV blood-screening test. Today, Abbott Laboratories continues to play a crucial role in improving health outcomes worldwide, with its cutting-edge technology and a focus on delivering quality healthcare solutions.
Abbott Laboratories has achieved several significant milestones throughout its history. One major milestone was the development and commercialization of the first-ever HIV blood screening test, which greatly contributed to safer transfusions and the prevention of the spread of HIV. Additionally, Abbott Laboratories introduced breakthrough medical devices, such as the FreeStyle® Libre system, a continuous glucose monitoring system for diabetes management. The company also played a crucial role in the fight against COVID-19 by developing rapid diagnostic tests for the virus. Furthermore, Abbott Laboratories has consistently been recognized for its commitment to innovation and sustainability, making it a leading healthcare company globally.
Abbott Laboratories is primarily present in multiple countries and regions worldwide. The company operates in more than 160 countries, including the United States, Canada, Europe, Asia-Pacific, Latin America, and the Middle East. With a strong global footprint, Abbott Laboratories has established itself as a leading healthcare company in various markets, delivering innovative medical products, diagnostics, nutritionals, and pharmaceuticals to improve people's health and well-being.
Abbott Laboratories is committed to its core values of putting patients first, serving customers with innovative solutions, and operating with integrity in all aspects of its business. The company's corporate philosophy centers around improving life through the development of groundbreaking technologies and products. Abbott Laboratories prides itself on its dedication to delivering reliable healthcare solutions, fostering collaboration with healthcare professionals, and investing in research and development to address unmet medical needs. With a focus on providing high-quality and accessible healthcare options, Abbott Laboratories strives to create positive impacts in communities worldwide through its diverse portfolio of medical devices, diagnostics, nutrition, and pharmaceutical products.
Analistler şu anda Abbott Laboratories hissesi için ortalama 123,64 USD hedef fiyat belirliyor (medyan: 121,00 USD); bu, son fiyata göre +20,5 % anlamına gelir. Konsensüs 32 analist notuna dayanır.
32 analist şu anda Abbott Laboratories hissesini değerlendiriyor: 26 al, 6 tut, 0 sat öneriyor. 2026 için analistler Abbott Laboratories şirketinin 50,30 Md USD gelir ve 5,52 USD hisse başına kâr üretmesini bekliyor.
Güncel döviz kuruyla Abbott Laboratories hissesi 91,96 EUR (102,64 USD) seviyesindedir.
Abbott Laboratories hissesi (ABT) 9 borsada işlem görür, bunlar arasında: NYSE (ABT), London (0Q15.L), SIX (Zürich) (ABT.SW), XETRA (ABL.DE), Frankfurt (ABL.F), München (ABL.MU), Düsseldorf (ABL.DU), Hamburg (ABL.HM).
Abbott Laboratories is a global company specializing in the development, manufacturing, and marketing of health products and services. Its business model is divided into different divisions that focus on the needs of patients, doctors, and healthcare systems. The divisions of Abbott Laboratories include Diagnostics, Medical Devices, Nutrition, and Pharmaceutical. The company aims to continuously develop innovative technologies and products to improve healthcare, and it offers a wide range of services and support programs for patients. Abbott Laboratories has established a strong market position and global presence in over 160 countries since its establishment in 1888. It also pursues a successful acquisition strategy to expand its product portfolio, such as the acquisition of St. Jude Medical in 2017 to enhance its cardiovascular products and services. Overall, Abbott Laboratories aims to improve healthcare and meet the needs of patients, doctors, and healthcare systems through its comprehensive strategy focused on developing innovative products, expanding into new markets, and increasing efficiency.
beklenen'nin Abbott Laboratories hasılatı 50,30 Md USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
beklenen'nin Abbott Laboratories karı 9,64 Md USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Abbott Laboratories'nin Fiyat/Kazanç (F/K) oranı şu anda 18,59'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Abbott Laboratories hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Abbott Laboratories'nin Fiyat/Satış (F/S) oranı şu anda 3,56'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Abbott Laboratories hisse senedinin değerleme metriği olarak hizmet eder.
Abbott Laboratories'nin Eulerpool Kalite Puanı 6/10'dur.
Abbott Laboratories'nin ISIN'i US0028241000'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Abbott Laboratories'nin WKN'i 850103'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Abbott Laboratories'nin ticker'ı ABT'dir. Ticker sembolü, Abbott Laboratories hisseleri borsada işlem görmek için kullanılır.
Abbott Laboratories Hissesi
Abbott Laboratories Emsaller Grubu
Abbott Laboratories Ticker
Abbott Laboratories FIGI
Abbott Laboratories'nin tüm temel göstergeleri ve derinlemesine analizi
Abbott Laboratories hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Abbott Laboratories şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: